Search

everythinglearnresearchcommunity

for

Search:↓

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

High levels of androgens during early development may cause PCOS-like symptoms.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

New compounds may soon be tested to treat excessive hair growth in women.

Aromatase inhibitors cause male pattern hair loss in women.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

New methods have helped find cells that create other cells in the body.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

New treatments for PCOS focus on managing symptoms and improving fertility.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The vellus index is a simple, quick, and reliable method to assess and monitor hair growth, especially in hirsutism.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.